4//SEC Filing
Brake Rachael Louise 4
Accession 0001209191-21-068508
CIK 0001595097other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:04 PM ET
Size
5.6 KB
Accession
0001209191-21-068508
Insider Transaction Report
Form 4
Brake Rachael Louise
Chief Scientific Officer
Transactions
- Award
Stock Option(right to buy)
2021-12-06+500,000→ 500,000 totalExercise: $0.75Exp: 2031-12-06→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on December 6, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on January 6, 2023.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001898023
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:04 PM ET
- Size
- 5.6 KB